Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 54, Issue 2, Pages 557-562Publisher
OXFORD UNIV PRESS
DOI: 10.1093/jac/dkh328
Keywords
carbapenems; beta-lactams; imipenem; meropenem
Ask authors/readers for more resources
Objective: To compare the in vitro activities of the carbapenem, CS-023, four representative beta-lactam antibiotics and levofloxacin, against 970 Gram-positive or Gram-negative US clinical isolates. Methods: Susceptibilities of bacteria chosen for their varying levels of resistance to the comparator agents were determined by NCCLS microdilution methodology. Results: CS-023 exhibited activity comparable to that of imipenem against most Gram-positive isolates, but was similar to8-fold more potent against oxacillin-resistant staphylococci. It was comparable to meropenem against most Gram-negative isolates, but was 4- to 8-fold more potent against five isolates of meropenem-resistant Pseudomonas aeruginosa. Conclusions: If tissue and body fluid concentrations >8 mg/L can safely be achieved, further studies of CS-023 are warranted to determine its clinical efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available